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IgG subclasses in patients with membranoproliferative
glomerulonephritis, membranous nephropathy, and lupus
nephritis
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Third Department of Internal Medicine, Akita University School of Medicine, Akita City, Japan
IgG subclasses in patients with membranoproliferative glomerulone-
phritis, membranous nephropathy, and lupus nephritis. Primary gb-
merulopathy can be classified into seven essential patterns based on
histopathological studies. The pathogenesis of membranoproliferative
glomerulonephritis (MPGN), and membranous nephropathy (MN), which
show glomerular JgG deposition and induce mainely nephrotic syndrome,
is not known. To clarify the role of lgG subclass in glomerulonephritis, we
compared serum concentrations of IgG subclasses, the ratio of serum IgG
subclasses to total IgG (%IgG subclass), and glomerular deposition of TgG
subclasses between 7 MPGN patients, 21 MN patients, and 9 lupus
nephritis (LN) patients. Serum TgG subclasses and %IgG in all groups
were almost within normal range based on the values in Japanese healthy
adults. In the MPGN and MN groups, the IgGi concentration was
significant lower than that of the LN group (P < 0.001, P < 0.0001,
respectively). The IgG2 concentration in the MPGN group decreased
significantly compared with that in the LN group (P < 0.05). The %IgG2
of the LN group decreased significantly compared with that of the MN
group (P < 0.05). The %IgG3 of the MPGN group was significantly higher
than that of the MN group (P < 0.05). The gbomerular immunoflourescent
intensity of IgGi and IgG2 were significantly stronger in the LN group
than in the MPGN and MN groups (IgGI, P < 0.001, P < 0.01,
respectively; IgG2, P < 0.0001, P < 0.0001, respectively). IgG3 in the
MPGN and LN groups deposited significantly compared with that in the
MN group (P < 0.0001, P < 0.01, respectively). The intensity of IgG4 in
the MN group showed a significant difference compared with that in the
MPGN and LN groups (P < 0.0001, P < 0.01, respectively). IgG3 is an
important factor in the pathogenesis of primary MPGN, while IgG4
relates to gbomerular IgG deposition in MN.
Primary glomerulopathy is classified into seven essential types
based on the light microscopic findings according to WHO
classification [1]. Membranoproliferative glomerulonephritis
(MPGN) is uniquely characterized by enlarged and lobular gb-
meruli, increased mesangial cells and matrices, and a double
contour of the capillary loop. Although the incidence of this
disease is very low, 1 to 2% of glomerular diseases, MPGN can
develop into steroid-resistent nephrotic syndrome, with more than
half of all MPGN-patients suffering chronic renal failure. The
pathogenesis is still unknown even though the role of an activated
complement system has been emphasized [21. Membranous ne-
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phropathy (MN) shows subepithelial IgG deposition under immu-
nofluorescent study, and a bubbling appearance with spike for-
mations on periodic acid methenamine silver (PAMS) stains
under light microscopic study. It is still unclear why IgG, which is
larger than albumin, is present on the outer side of the glomerular
basement membrane. IgG is divided into four subclasses: IgGi,
IgG2, IgG3, and IgG4. Each subclass differs at several points on
the encoded gene, molecular weight, isoelectric point, and inter-
action to complements, and other biological functions also differ
between subclasses. The present study was designed to evaluate
the role of IgG subclasses in humoral immune-related glomeru-
bonephritis such as MPGN, MN, and lupus nephritis (LN).
Methods
Patients
We selected 37 kidney-disease patients who were admitted to
Akita University Hospital and its affiliated hospitals between 1992
and 1995. Using kidney biopsies based on hematoxylin-eosin (H &
E), PAS, Heidenhain's azocarmine aniline blue, and Jone's peri-
odic acid methenamin silver (PAMS) stains, histopathological
diagnoses were made according to WHO classification [1].
MPGN was defined by light microscopy as enlarged and lobular
glomeruli, an increase in mesangial cells and matrices, and a
double contour of the capillary loop. There were 62 patients with
MPGN-lesions out of a total of almost 3,000 renal biopsies
between 1979 and 1995. The number of primary MPGN cases
without systemic diseases was 33. In this study, patients with
monoclonal nephropathy (light and heavy chain deposition dis-
eases, cryoglobulinemia), Crow-Fukase syndrome (Takatsuki's
disease), anti-phospholipid antibody syndrome (as classified by
Rennke [3]), lupus nephritis, other autoimmune diseases, and
hepatitis B or hepatitis C viral infections were excluded from the
primary MPGN group. Of these 33 primary MPGN cases, only the
7 most recent cases were used for this study.
MN was defined as subepithelial IgG deposits without either
systemic diseases, such as hepatitis B or C, or autoinimune
diseases. Of approximately 200 patients with primary MN, only
the 21 most recent cases were used for this study.
The diagnosis of systemic lupus erythematosus (SLE) was based
on the ARA's criteria of 1984, while the histopathological analysis
of lupus nephritis (LN) was based on the WHO classification [1].
The 9 most recent cases (one WHO-IVa, four WHO-bVb, two
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Fig. 1. Immunofluorescent study of a patient
with MPGN (MPGN-5). IgG3 deposited as four
plus (score: 4.0). IgGI, IgG2, and IgG4 were all
negative.
Fig. 2. Immunofluorescent study of a patient
with MN (MN-Jo). TgG4 was graded as four
plus (score: 4.0). IgGi and IgG2 were one plus
(score: 1.0), JgG3 was negative.
Wi-lO-Va, one WHO-Vc, and one WHO-Vd) were used for this 1.0), two plus (score 2.0), and three plus (score 3.0). This
study. assessment was performed by three observers who did not know
the background data.
Immunofluorescent study
Sections of 4 to 5 jim were stained with fluorescen-conjugated Serum samples
monospecific rabbit anti-human kappa and lambda light chains, Sera were obtained from 7 MPGN patients, 21 MN patients,
Clq, C3, flbrinogen, heay chain-specific anti-IgG, IgA, and 1gM and 9 lupus nephritis (LN) patients, and stored at —80°C.
antibodies (DAKO A/S, Denmark), mouse monoclonal anti-
human IgGi (Fe), anti-human IgG2 (Fab), anti-human IgG3 Immunoassay of human IgG subclasses(F(ab')2), and anti-human lgG4 (pFc')(lO-fold dilution) (The
Binding Site Ltd, UK). Immunofluorescent intensity was graded Immunoassay of human I gG subclasses was carried out accord-
as: negative (score 0), weakly positive (score 0.5), one plus (score ing to the methods of Bird et al [4]. Microtiter plates (Nunc Co.)
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Table 1. Patient profiles
were treated with 100 j.tl/well of mouse monoclonal anti-human
IgGI, lgG2, IgG3, and IgG4 antibodies (Oxoid Limited, UK), as
recommended by WHO, at a concentration of 10 j.tg/ml. They
were then incubated with 0.25% bovine serum albumin (BSA) in
PBS (p1-I 7.2) to block nonspecific protein binding sites. To
determine the IgG subclass, 100 .d of each sample was added to
each well in duplicate. WHO reference serum 67/97 was used as a
standard concentration. After incubation at 37°C for one hour,
the plates were washed with PBS-Tween. Peroxidase conjugated-
purffied anti-human IgG (DAKO AJS) was then added to each
well and the plates incubated for one hour at 37°C. The plates
were again washed with PBS-Twcen before 100 1.d of OPD-H2O2-
citrate phosphate buffer was The enzymatic reaction was
stopped after 30 minutes by the addition of 50 pd of 3 N H2S04 per
well, and the reaction product quantitated by measuring absor-
bance at 492 nm with a microtiter spectrophotometer. The ratio of
IgG subclass (%IgG subclass) was calculated as the value of the
concentration of one subclass divided by the total of' all IgG
subclasses.
Statistical analysis
We compared the serum concentration, the ratio, and the
glomerular intensity of the lgG subclasses of the MPGN, MN, and
LN groups using Student's t-test and ANOVA analysis.
Results
Background of patients
Patient information for each group is summarized in Table 1.
The average ages for the MPGN, MN, and LN groups were 37.4,
54.9, and 32.3 years old, respectively. The numbers of patients
showing heavy proteinuria (more than 3.0 g/day) were 3 in the
MPGN group, 10 in the MN group, and 5 in the LN group.
Hypoproteinemia was observed in 4 out of 7 MPGN-patients, 12
out of 21 MN-patients, and 5 out of 9 LN-paticnts. Hypocomple-
mentemia (CH5O below 30) was observed in 5 of the 6 MPGN-
patients examined, 1 of the 15 MN-patients examined, and all 8
LN-patients examined.
IgGI IgG2 lgG3 IgG4
Age Sex
UP
giday
TP
gIdI
C3
mgldl
CH5O
30—40 mgldl
MPGN-1
MPGN-2
MPGN-3
MPGN-4
MPGN-5
MPGN-6
MPGN-7
66
25
14
18
48
22
69
M
F
M
M
F
F
F
2.5
3.1
7.8
1.9
5.4
1.1
1.1
4.8
4.7
4.4
6.1
4.0
6.3
6.0
58
<10
<10
12
49
NA
64
18
14
<8
15
21
NA
32
28
<12
<12
13
25
NA
36
268.2
682.2
470.3
661.2
183.0
970.6
428.5
111.6
370.2
91.6
153.1
92.6
431.9
207.7
11.2
42.3
81.6
65.6
6.6
134.0
43.2
22.0
1.9
2.1
22.3
20.5
28.4
22.5
MN-i
MN-2
MN-3
MN-4
MN-S
MN-6
MN-7
MN-8
MN-9
MN-10
MN-il
MN-12
MN-13
MN-14
MN-iS
MN-16
MN-17
MN-18
MN-19
MN-20
MN-21
60
40
38
50
72
42
53
45
78
39
46
57
5t)
37
40
79
62
66
65
74
60
M
F
M
M
M
M
M
M
F
F
F
F
M
M
F
M
M
F
M
F
M
5.0
2,0
1.5
19.4
2.5
2.0
12.1)
1.8
7.0
0.5
5.0
0.7
2.3
3.7
1.5
4.0
11.0
2.4
3.0
2.5
16.0
4.7
4.5
7.8
4.4
6.1
6.3
5.1
5.1
5.1
6.1
4.7
6.5
6.7
6.0
7.1
4.9
5.3
5.2
4.8
6.2
5.0
76
NA
88
84
NA
72
92
33
110
72
99
NA
102
91
71
NA
111
98
121
NA
123
45
NA
25
41
NA
30
38
16
55
32
42
NA
33
23
30
NA
50
40
40
NA
71
41
NA
39
40
NA
36
36
25
45
40
40
NA
40
37
44
NA
43
39
NA
NA
60
335.9
534.3
881.1
129.1
1323.8
417.7
157.1
795.6
611.5
518.8
351.8
949.4
925.5
568.2
509.3
449.0
809.7
521.9
470.3
728.2
439.5
317.2
151.3
731.3
77.5
210.3
233.9
183.3
385.6
271.3
282.4
156.6
498.8
344.0
484.6
682.8
307.2
358.3
297.6
320.4
298.4
223.4
18.3
9.8
45.0
4.1
80.6
11.3
13.7
98.9
18.4
20.1
17.1
48.4
100.6
50.2
32.8
46.4
96.1
13.3
46.0
43.7
21.9
49.6
5.2
45.7
15.6
229.6
16.2
14.1
23.4
30.6
6.6
13.8
22.0
26.5
36.1
23.3
26.6
250.9
2.6
18.0
47.6
35.1
LN-1
LN-2
LN-3
LN-4
LN-5
LN-6
LN-7
LN-8
LN-9
34
23
19
25
32
49
47
15
47
M
F
F
F
F
F
F
M
F
5.9
7.7
3.7
4.1
3.0
2.4
0.7
2.0
2.2
5.8
6.2
5.3
6.6
6.2
5.0
4.2
6.8
5.5
38
20
NA
51
31
29
51
<21
25
7
5
NA
13
10
6
12
<2
6
16
13
NA
28
25
16
28
<10
11
1658.6
1199.7
981.3
642.3
1632.6
958.5
1693.8
1663.0
1168.3
410.3
506.8
491.1
92.2
286.3
570.8
460.5
384.5
773.3
51.3
122.2
113.9
29.3
52.0
35.5
45.0
89.1
82.9
181.3
0.3
18.7
36.2
0.5
42.7
141.4
279.4
34.1
lower limit
upper limit
42.3
1224.9
232.5
1361.5
15.8
126.2
3.2
220.0
Healthy control
NA is not available.
Table 2. IgG subclass between MPGN, MN, and LN
IgGi IgG2 IgG3 lgG4
Concentration
MPGN 523.4 102.0 208.6 52.4 55.0 16.7 17.1 4.0
MN 591.9 61.8 324.5 35.6 39.6 6.8 44.6 14.5
LN 1288.8 129.3 441.8 62.8 69.0 11.4 81.4 32.4
% IgU subclass
MPGN 65.3 2.1 26.7 2.8 6.2 1.4 2.9 0.9
MN 58.8 2.0 33.6 2.1 3.6 4.1 4.0 0.9
LN 68.8 3.0 23.4 3.2 3.9 6.4 4.0 1.3
IF intensity
MPGN 0.4 0.2 0.1 0.1 2.9 0.5 0.5 0.2
MN 0.8 0.1 0.8 0.1 0.2 0.1 2.5 0.2
LN 1.9 0.3 2.2 0.3 1.6 0.4 1.3 0.3
Data were expressed as mean SE.
Serum concentration in the IgG subclasses
Compared with the normal value of Japanese healthy adults [5],
the serum concentration and the ratio of IgG subcalsses/total IgG
were almost within the normal range except for the elevation of
serum IgGi in LN group.
In the MPGN and MN groups, the IgGi concentration was
significantly lower than that of the LN group (P < 0.001, P <
0.0001, respectively). The IgG2 concentration in the MPGN
group decreased significantly compared with that in the LN group
(P < 0.05). IgG3 and IgG4 did not show any significant difference
between groups (Tables 1 and 2; Figs. 4, 5, 6 and 7).
The ratio of IgG subclass/total IgG (%!gG subclasses)
%IgGl and %IgG4 showed no significant difference between
the three groups. The %IgG2 of the LN group decreased signif-
icantly compared with that of the MN group (P < 0.05). The
%lgG3 of the MPGN group was significantly higher than that of
the MN group (P < 0.05; Tables 1 and 2, and Figs. 4—7).
immunofluorescent intensity of IgG subclasses (IF-intensity of IgG
subclasses)
Patterns of glomerular IgG subclass deposition for patients of
each group are shown in Figures 1, 2 and 3. lgG3 was deposited
predominantly in the MPGN group, while IgG4 was deposited
predominantly in the MN group. In the LN group, IgGi and IgG2
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%lgGl %IgG2 %IgG3 %IgG4 IF-IgGi IF-IgG2 IF-IgG3 IF-IgG4
-
Comment
64.9
62.2
72.8
73.3
60.5
62.0
61.0
27.0
33.8
14.2
17.0
30.6
27.6
29.6
2.7
3.9
12.6
7.3
2.2
8.6
6.2
5.3
0.2
0.3
2.5
6.8
1.8
3.2
0.0
0.0
2.0
0.0
0.0
0.5
0.0
0.0
0.0
1.0
0.0
0.0
0.0
0.0
4.0
3.0
4.0
1.0
4.0
2.0
2.0
0.0
1.0
1.0
0.5
0.0
1.0
0.0
46.9
76.3
51.7
57.0
71.8
61.5
42.7
61.0
65.6
62.7
65.2
62.5
66.3
49.9
40.8
54.1
53.4
62.5
55.0
65.1
61.1
44.3
21.6
42.9
34.2
11.4
34.4
49.8
29.6
29.1
34.1
29.0
32.8
24.6
42.5
54.7
37.0
23.7
35.6
37.5
26.7
31.0
1.9
1.4
2.6
1.8
4.4
1.7
3.7
7.6
2.0
2.4
3.2
3.2
7.2
4.4
2.6
5.6
6.3
1.6
5.4
3.9
3.0
6.9
0.7
2.7
6.9
12.4
2.4
3.8
1.8
3.3
0.8
2.6
1.4
1.9
3.2
1.9
3.2
16.6
0.3
2.1
4.3
4.9
1.0
2.0
0.5
1.0
1.0
1.0
0.0
0.0
2.0
0.0
1.0
1.0
1.0
0.5
1.0
1.0
0.0
0.5
0.5
0.0
1.0
1.0
2.0
0.0
1.0
1.0
2.0
0.0
0.5
0.0
0.0
0.0
0.0
1.0
2.0
1.0
1.0
0.5
1.0
1.0
0.0
1.0
0.5
0.5
0.0
0.0
0.5
0.0
0.0
0.5
0.0
0.0
0.0
0.0
0.5
0.0
1.0
0.0
1.0
0.0
0.0
0.0
0.0
3.0
3.0
0.5
3.0
1.0
3.0
2.0
1.0
3.0
2.0
2.0
1.0
3.0
3.0
3.0
4.0
3.0
4.0
2.0
4.0
2.0
72.1
65.6
61.1
80.3
82.8
59.6
72.4
68.8
56.8
17.8
27.7
30.6
11.5
14.5
35.5
19.7
15.9
37.6
2.2
6.7
7.1
3.7
2.6
2.2
1.9
3.7
4.0
7.9
0.0
1.2
4.5
0.0
2.7
6.0
11.6
1.7
1.0
2.0
3.0
1.0
3.0
1.0
2.0
3.0
1.0
1.0
1.0
3.0
2.0
3.0
3.0
2.0
3.0
2.0
0.5
0.5
3.0
0.0
3.0
1.0
2.0
3.0
1.0
2.0
0.0
1.0
2.0
2.0
1.0
1.0
2.0
(1.5
31.5
72.4
20.4
62.7
1.2
8.6
0.2
14.6
Stage lIT—TV
Stage 11
Stage I
Stage I
Stage I—Il
Stage I—Il
Stage I—TI
Stage II
Stage II
Stage H
Stage IT
Stage I—IT
Stage TI
Stage IT
Stage I
Stage I—TI
Stage I—if
Stage I—lI
Stage TI
Stage I
Stage I
WHO-Vc
WHO-Va
WHO-IVb
WHO-Va
WHO-Vd
WHO-IVIj
WHO-I Va
WHO-IVb
WHO-TVb
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Fig. 3. Immunofluorescent study of a patient
with LN (LN-3). IgGI, IgG2, and IgG3 were
three plus (score: 3.0), IgG4 was one plus
(score: 1.0).
were massively deposited. The intensity of IgGI and IgG2 in the
LN group was significantly stronger than that of the MPGN and
MN groups (IgGi, P < 0.001, P < 0.01, respectively; lgG2, P <
0.0001, P < 0.0001, respectively). IgG3 deposition in the MPGN
and LN groups was significant compared with that of the MN
group (P < 0.0001, P < 0.01, respectively). The intensity of IgG4
in the MN group showed a significant difference to that of the
MPGN and LN groups (P < 0.0001, P < 0.01, respectively; Tables
I and 2, and Figs. 4—7).
Discussion
This study demonstrates that 1g03 relates to menibranoprolif-
erativc glomerulonephritis (MPGN), and that lgG4 is an impor-
tant factor in membranous nephropathy (MN). lgG divides into
four subclasses according to the molecular weight, isoelcctric
point, carbohydrate content, the number of disulfide bonds in the
constant region of the heavy chain, and immunogenecity. Such
structual differences induce functional differences in complement
activation capacity, as well as in the binding activity to the Fcy
receptor. The half-life of IgG3 is about seven days, while the
half-life of the other subclasses is almost 23 days. The serum
concentrations of IgGI, IgG2, IgG3, and IgG4 were approxi-
mately 900 mg/dl, 300 mg/dI, 100 mgldl, and 50 mg/dl, respectively.
Embryological analysis revealed that IgG3, a strong initiater of
complement activation, is the oldest subclass of the IgOs, while
lgG4, with no complement activation, is the newest one [6]. Our
results suggest that IgG subclass determines the phenotype of
glomerulonephritis.
Diagnosis of MPGN is based on enlarged glomcruli, mesangial
cell proliferation, a double contour capillary loop, and lobular
formation as observed under light microscopy. However, such
pathological traits are also seen in other conditions. Recently,
Rcnnke (3] classified MPGN into three major types: the immune
complex-related type, the anti-phospholipid antibody-related
type, and the paraproteinemia-related type. Primary MPGN is
defined as the unknown cause of the immune complex-related
type. We received 62 cases of MPGN over 16 years, 33 of whom
were diagnosed with primary MPGN. All 7 primary MPGN cases
in this study (those presenting with primary MPGN in the last 4
years), showed predominant IgG3 deposition in glomeruli, and a
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Fig. 7. Serum concentration of IgG4, %IgG4,
and glomerular deposition of IgG4.
significantly higher ratio of lgG3/total lgG in sera compared with
that of the membranous nephropathy cases. We excluded one
patient having no immune deposition from primary MPGN in
present study, because he had advanced gastric cancer. Regarding
the relationship between IgG3 and MPGN, Thompson [7] re-
ported that the elevated serum levels of EgG3 existed in MPGN-
patients with hypocomplementemia. In 1989, Strife, Leaby and
West [8] and in 1992, Prada and Strife [9] demonstrated that
IgG3-class anti-Clq antibodies increased in patients with MPGN.
As for the glomerular deposition of IgG3, Banister et a! [101 first
reported a predominant lgG3 deposition in 6 patients with
MPGN in 1983. Our present study confirms both the elevated
serum IgG3 levels, and glomerular lgG3 deposition in patients
with MPGN. It has been proposed that viral infections such as
herpes, cytomegalovirus, hepatitis B or C, as well as influenza in
cases of elderly patients, increase IgG3 subclass antibodies [11].
lgG3 class-antibody reacting with HCV C-100 antigen epitopes is
precipitated under cold conditions [12]. Immune complex-related
type of primary MPGN would, according to Rennke's classifica-
tion [31, be related to lgG3, because IgG3 is the strongest initiater
of complement activation. The detection of IgG3 in glomeruli is a
useful indicator for the discrimination between immune complex-
type MPGN (primary) and mesangiolytic type MPGN (second-
ary).
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Fig. 6. Serum concentration of IgG3, %IgG3,
and glomentlar deposition of IgG3.
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Although patients with membranous nephropathy in our study
showed no significant difference in lgG4 serum concentration,
with the cxception of an increased ratio of IgG2/total IgG,
Bannister et a! [10] revealed larger amounts of deposited IgG4
than IgG3 in the glomeruli of MN patients. Also, Doi et al
reported that 12 patients with MN showed a predominant IgG4
deposition in the capillary loop [13]. In 1992, Iskandar, Falk and
Jeannette [14] demonstrated that patients with MN and fibrillary
glomerular nephropathy had predominant IgG4 deposition on the
outer basement membrane. In 1994, Haas [15] reported that 6 out
of 7 patients with MN showed predominant IgG4 deposition. Our
present study confirms the above observations that membranous
nephropathy is mainely glomerular IgG4 deposition, even though
there is no elevation in serum IgG4 levels. The present data may
depend on the specificity of monoclonal antibodies to IgG sub-
classes. Recently, Brekke, Michaelson and Sandlie [16] revealed
that IgG3 has more disulfide bonds in the CH2 region than does
IgG4, and that these disulfide bonds are close to the complement
activation activity. IgG4 should easily separate in the CH2 region
to half its molecular size. IgG4 or IgG4 immune complexes induce
subepithelial deposits, and injure the charge- and size-barriers of
the glomerular basement membrane. This process may be related
to membranous nephropathy. Studies of lgG4 immunology using
molecular immunogenetics will reveal following problems:
whether patients with MN have genetic abnormalities to induce
subclass-switch to IgG4; whether IgG4 from patients with MN
easily become a half its molecular size by molecular abnormality;
and whether IgG4 from MN has a tendency to bind glomerular
basement membrane and/or glomerular epithelial cells.
In lupus nephritis, all subclasses of IgG increased in sera, with
IgG2 depositing predominantly in glomeruli, differing in pattern
to that of MPGN and MN groups. Three out of 4 diffuse
membranous type LN (WHO-V) showed glomerular IgG4 depo-
sition (score 2.0). These patients with subepithelial deposits
similar to those found in MN patients showed IgG4 deposition
along the basement membrane. Other patients with predominant
mesangial cell proliferation (WHO-IV) had IgGI, IgG2, and IgG3
deposition in the mesangial or subendothelial area. The decreased
level of serum %IgG2 and the increased glomerular IgGi and
lgG2 deposition suggest that IgGI and IgG2 immune complexes
are important factors in lupus nephritis. The above results are
compatible with the observations of Haas [15].
The phenotype of primary glomerulonephritis depends on less
IgG (IgG3 and/or IgG4) amounts in sera. Further studies about
the IgG subclasses should reveal the mechanism of MPGN and
MN.
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